Business
AstraZeneca Invests $2 Billion in Summit Oncology Treatment
AstraZeneca invests $2 billion in Summit Therapeutics in a partnership featuring clinical trials to test combination oncology treatments, including ivonescimab for lung and gastrointestinal…
